In Extended Anticoagulant Treatment With a Reduced Versus Full Dose Apixaban in Patients With Cancer-Associated Venous Thromboembolism, get a deep dive into the API-CAT late-breaking clinical trial presented at ACC.25! It's just one of more than a thousand presentations from the conference, including inspiring keynotes, cutting-edge late-breaking clinical trials, thought-provoking panels and more. ACC.25 attendees with full three-day conference professional registration receive a FREE one-year subscription to ACC Anywhere – login to activate your account. Didn't attend ACC.25? Enjoy a free preview and subscribe to watch the full video, plus thousands more from ACC's top meetings!

Join Michelle Kittleson, MD, FACC, and ACC's expert faculty for a new interactive online activity, "Diagnostic Testing for Amyloidosis," as part of ACC's free Cardiac Amyloidosis: Accelerating Diagnosis and Treatment online course. Learn to spot clinical clues of cardiac amyloidosis, select the appropriate sequence of testing and recognize the diagnostic results. Plus, earn 0.75 CME/AAPA/ICPE credits and MOC points! Learn more.

Access on-demand videos from ACC's Advancing the Cardiovascular Care of the Oncology Patient course, now available on ACC Anywhere. Presentations tackle topics crucial to the intersection of cardiovascular care and oncology, including risk stratification, pharmacology and radiology. Learn from experts as they take you through discussions, case challenges and more – all at your convenience. Subscribe to ACC Anywhere to start watching!

Join Vivek Kulkarni, MD, FACC, on Friday, March 28 from 1-5 p.m. CT, for a pre-conference workshop designed for navigating the world of research and evidence-based guidelines – with special focus on the TAVR-Unload Trial and 2020 ACC/AHA Valve Disease Guideline. Practice applying JACC articles and clinical guidelines to a real-world case, with guidance from expert coaches in the field, including Sandra M. Oliver-McNeil, DNP, ACNP-BC, FACC; Erica Spatz, MD, FACC; and Muthiah Vaduganathan, MD. Register today for ACC.25, taking place March 29-31 in Chicago, and add the JACC Workshop to your registration. Already registered? Login to your attendee dashboard to add the workshop to your registration.

JACC: CardioOncology recognizes the importance of education, research and advocacy in advancing the understanding and management of amyloidosis. Check out the journal's Amyloidosis Hub, highlighting recent original research, educational clinical case challenges, videos, podcasts and more. Explore today.

Join ACC's Cardio-Oncology Member Section for networking and updates in the field at the Cardio-Oncology Section Meet-Up, taking place during ACC.25 on Sunday, March 30, from 5-6 p.m. CT in the Lounge & Learn Pavilion, Meet-Up Zone 2. Encourage your colleagues to attend – all ACC members are welcome to attend and learn more about the section. Register today!

Check out a new slide lecture, "Cardiac Amyloidosis Foundations," as part of ACC's free online course, Cardiac Amyloidosis: Accelerating Diagnosis and Treatment. Learn to identify symptomology of cardiac amyloidosis, select appropriate testing, and recognize findings suggestive of amyloidosis including biomarkers and echo. Plus, earn 1.25 CME/AAPA credits and MOC points. Learn more.

The latest impact factor for JACC: CardioOncology illustrates how integral of a resource the journal has become for ACC members. The journal provides a platform for sharing the latest, ground-breaking science to help advance cardio-oncology care. Read the latest issue today and subscribe to JACC Journals email alerts to stay up to date on the latest science.

Join your colleagues at ACC.25, taking place March 29-31, 2025, in Chicago, IL, and get the knowledge you need to transform cardiovascular care for all! You'll have the opportunity to discuss the latest science with top experts, learn how clinical guidelines translate into your daily practice, and build lasting connections with your peers. Register by Nov. 20 to SAVE up to $300 with early bird discounts and get all-inclusive access to ACC.25!

Transform the future of patient care by sharing your late-breaking clinical trial (LBCT) research with the global cardiovascular community at ACC.25, taking place March 29-31, 2025, in Chicago, IL.

Join leading experts, including Course Chair Richard Cheng, MD, MSc, FACC, and Vice Chair Anju Nohria, MD, MSc, at Advancing the Cardiovascular Care of the Oncology Patient taking place in Washington, DC and virtually Feb. 14-16, 2025. Register here. Plus, don't miss your chance to present your research on the topic of cardio-oncology! All members of the cardiovascular team are invited to submit abstracts in the categories of Clinical Case Challenges, Original Research Abstracts: Basic, Translational, Clinical or Implementation Science, Professional Development Abstracts. Submissions are due by Nov. 18.

The ACC is currently accepting submissions of abstracts, complex clinical cases and interventional challenging cases to be presented at ACC.25, taking place March 29-31, 2025, in Chicago, IL. Submit your research for a chance to transform the future of cardiovascular care by sharing your research with over 12,000 attendees from more than 130 countries. The deadline for all submissions is 1 p.m. ET on Tuesday, Oct. 1. Don't miss your chance to be part of ACC.25 — submit your abstract or case today!

JACC: CardioOncology is calling for submissions for a special focus issue examining the basic, translational, and clinical science in the emerging area of "Bi-Directional Cardio-Oncology." Innovative original scientific investigations rigorously defining the mechanistic and epidemiologic overlap between cancer and cardiovascular disease, independent of cancer therapy, as well as the potential for new mechanistic therapies that can effectively target both diseases would be of interest. Submissions are due by Feb. 15, 2025. Learn more.

Registration is now open for ACC's Advancing the Cardiovascular Care of the Oncology Patient, taking place Feb. 14-16, 2025, in Washington, DC, and virtually. Join Course Chair Richard Cheng, MD, MSc, FACC, Vice Chair Anju Nohria, MD, MSc, and other leading cardio-oncology experts as they share emerging strategies and best practices to advance patient-centered, evidence-based collaborative cardiovascular and cancer care for patients living with and beyond cancer. This educational experience will keep you on the leading edge of this rapidly evolving field! The deadline for early registration rates is Oct. 9, register today!

The latest issue of JACC: CardioOncology contains a variety of scientific content, including a mini-focus issue on radiation. The mini-focus issue looks at topics such as balancing the side effects and cost of left-sided breast radiotherapy, cardiac tumors and innovations in local therapies, and more. Additionally, don't miss a state-of-the-art review on "Cardiovascular Disease after Hematopoietic Stem Cell Transplantation in Adults," where readers gain CME credit! Read the full issue.

Join your fellow Section members at the Cardio-Oncology Section Meeting for a special welcome address from section chair Anita Deswal, MD, MPH, FACC, followed by updates and discussions on key topics in cardio-oncology from section leaders. Enjoy delicious refreshments and an open bar while you connect with colleagues and learn from the best. The event will take place Sunday, April 7 at 4 p.m. ET at Omni Atlanta at Centennial Park, Dogwood A. Reserve your spot today.

The ACC is seeking the next Vice Chair for ACC's Advancing the Cardiovascular Care of the Oncology Patient course.

JACC: CardioOncology has published an interactive Year in Review slideshow highlighting key facts about the journal's global reach and published research in 2023. The slideshow also includes titles and links to the top 15 most read and downloaded articles of 2023. Access it here.

Join top experts, including course chairs Ana Barac, MD, PhD, FACC and Bonnie Ky, MD, MSCE, FACC, and vice chair Richard Cheng, MD, FACC, in Washington, DC or virtually for Advancing the Cardiovascular Care of the Oncology Patient...

In this contemporary treatment era, the entire team needs to understand the different types of cancers and cancer therapies and their associated cardiovascular risks to help mitigate associated cardiovascular complications. Join top experts and course chairs, Ana Barac, MD, PhD, FACC, and Bonnie Ky, MD, MSCE, FACC, Feb. 9-11 in Washington, DC and virtually, for ACC’s Advancing the Cardiovascular Care of the Oncology Patient.

Two recent JACC: CardioOncology Pulse podcast episodes provide advice for aspiring cardiovascular investigators.

Join editorial board members from JACC: Heart Failure, JACC: Basic to Translational Science and JACC: CardioOncology during a Meet-and-Greet Reception during the HFSA Annual Scientific Meeting 2023.

JACC: CardioOncology is inviting submissions for a special issue examining the social and environmental determinants of health and health disparities in the global cardio-oncology patient population.

Have you activated your ACC Anywhere account? ACC Anywhere is the College’s new, on demand, personalized video library with 500+ hours of sessions from in-person and virtual conferences like ACC.23/WCC and the recent Advancing the Cardiovascular Care of the Oncology Patient course.

Tune in live on May 18 at 7 p.m. ET, for an ACC webinar on updated approaches for the use of multimodality cardiovascular imaging in patients with cancer and cardiovascular comorbidities.

Although ACC’s Advancing Cardiovascular Care of the Oncology Patient in-person meeting is sold out, there is still time to register for the virtual meeting, taking place April 14-16.

New content is available on the JACC: CardioOncology Pulse – a go-to resource for developing a career in cardio-oncology.

Find out what JACC: CardioOncology readers found most interesting in 2022 with a visual view of the central illustrations from the Journal’s most popular papers.

A new career development page from JACC: CardioOncology, JACC: CardioOncology Pulse, provides resources and insights for individuals exploring careers in cardio-oncology.

Attending ACC.23/WCC in New Orleans? Mark your calendars for these JACC Journals events!

JACC: CardioOncology has published a special focus issue dedicated to immune therapy. Articles include a state-of-the-art review on cancer immunotherapy beyond checkpoint blockade; current uses and future directions of immune checkpoint inhibitor therapy in oncology; atherosclerosis with immune checkpoint inhibitor therapy; and more.

Registration for ACC’s Advancing the Cardiovascular Care of the Oncology Patient is now open!

Cardiac amyloidosis is a cardiomyopathy caused by the infiltration of protein amyloid in the myocardium and surrounding tissues and is often unrecognized and underdiagnosed. The ACC has created the Cardiac Amyloidosis: Accelerating Diagnosis and Treatment online course to build competence in timely detection and diagnosis of this rare condition.

If you are presenting original research during SABCS or ASH, we invite you to submit your high-impact findings to JACC: CardioOncology for simultaneous publication.

The ACC invites you to join JACC: CardioOncology Editor-in-Chief Bonnie Ky, MD, MSCE, FACC, and members of the editorial board on Thursday, Oct. 6 from 4:45-6:30 p.m. at the poster reception during the Global Cardio-Oncology Summit (GCOS) 2022.

JACC: CardioOncology is inviting authors presenting research during the Global Cardio-Oncology Summit (GCOS) 2022 to submit to the Journal for simultaneous publication.

The latest issue of JACC: CardioOncology includes research dedicated to the growing knowledge surrounding physical activity and lifestyle interventions in cancer and cardiovascular disease.

The ACC is seeking a qualified candidate to serve as vice chair for ACC's Advancing the Cardiovascular Care of the Oncology Patient course.

The first issue of JACC: Advances published on April 1. Led by editor-in-chief, Candice Silversides, MD, the online, open-access journal covers the evolving aspects of cardiology, including emerging cardiovascular fields, diagnostics and treatments.

The March issue of JACC: CardioOncology is dedicated to growing the body of knowledge surrounding the intersection between cancer and cardiovascular disease. Each of the six original research manuscripts and research letter detail new knowledge on the epidemiologic and biologic links between cancer and cardiovascular disease.

Learn from top cardio-oncology experts, Ana Barac, MD, PhD, FACC and Bonnie Ky, MD, FACC at Advancing the Cardiovascular Care of the Oncology Patient – On Demand as they provide you with the best practices and emerging strategies needed in your everyday practice!

Find out what JACC: CardioOncology readers found most interesting in 2021.

Editor-in-Chief Bonnie Ky, MD, FACC, recently recorded a video discussion with Deepak L. Bhatt MD, MPH, FACC.

JACC: CardioOncology is accepting applications for the associate editor position until Feb. 1, 2022.

Aiming to expand the body of literature on emerging trends related to cardiovascular toxicities caused by immune therapies, JACC: CardioOncology will publish a uniquely themed issue highlighting this important area.

In the latest issue of JACC: CardioOncology, new research highlights the role of a healthy lifestyle in slowing the transition from cancer development to the development of cardiovascular disease and type 2 diabetes – and even reducing the risk.

JACC: CardioOncology is now accepting applications for the associate editor position until Feb. 1, 2022.

The newest JACC Journal, JACC: Advances, is now accepting submissions.

Registration is open for Advancing the Cardiovascular Care of the Oncology Patient Virtual! Join Course Directors Ana Barac, MD, PhD, FACC, and Bonnie Ky, MD, MSCE, FACC, and other cardio-oncology leaders Feb 11 – 12, 2022, to learn best practices and emerging strategies needed to advance patient care in everyday practice.

The ACC created the Managing AFib and BTK Inhibitors: Balancing Risk online course to educate the medical community about the importance of assessing risk, monitoring, and managing AFib and other cardiovascular risk factors for oncology patients.

Cardiac amyloidosis is a cardiomyopathy caused by the infiltration of protein amyloid in the myocardium and surrounding tissues and is often underdiagnosed.

The ACC created the Hypertrophic Cardiomyopathy: Accelerating Guideline-Driven Care online course to provide hypertrophic cardiomyopathy (HCM) educational resources and activities to accelerate guideline-driven care and improve patient outcomes.

JACC: Case Reports and JACC: CardioOncology are now fully indexed on PubMed Central, broadening access to the journals' cardiovascular research and educational content.

In a recent state-of-the-art review published in JACC: Basic to Translational Science, Anja Karlstaedt, MD, PhD; Matthew Barrett, BS; Ray Hu, MD, MTR; Seth Thomas Gammons, PhD, and Bonnie Ky, MD, MSCE, FACC, provide their insight on the intersection between cardiac metabolism and cancer biology.

Improve your knowledge in the field of adult clinical cardiology with ACCSAP. This self-assessment program offers 160 CME/MOC credits and includes over 600 case-based practice questions, 130 modules of text and 50 video presentations from the ACC Cardiovascular Overview and Board Prep course.

The ACC has created a free, online course: Raising Awareness and Understanding of Cardiac Amyloidosis to improve clinicians’ understanding of cardiac amyloidosis, which is often not recognized and underdiagnosed.

COVID-19, cancer, and cardiovascular disease disproportionally affect non-white populations, yet, these at-risk groups receive inadequate care due to long-lasting racial and ethnic health care disparities, according to two papers published in the June issue of JACC: CardioOncology.

There is growing evidence on the association between cancer and atrial fibrillation (AFib).

The latest issue of JACC: Case Reports features a mini-focus section on Cardio-Oncology.

Have thoughts about the Late Breaking Clinical Trials and Hot Topics? We want to hear them!

To provide helpful, practical and evidence-based knowledge to the clinical community, the latest issue of JACC: CardioOncology continues its popular "How to" series with articles on "How to Diagnose and Manage QT Prolongation in Cancer Patients" and "How to Manage Atrial Fibrillation Secondary to Ibrutinib."

Responding to the need for expanded knowledge on emerging trends, novel treatment approaches and outcomes for patients with AL and ATTR amyloidosis, JACC: CardioOncology will publish a special focus issue on this topic this year.

Bonnie Ky, MD, MSCE, FACC, editor-in-chief of JACC: CardioOncology will share strategies for developing a clinical research career, with examples of how to successfully ask and answer research questions in cardio-oncology, during a live webinar on April 20 at 10 a.m.

Purchase Advancing the Cardiovascular Care of the Oncology Patient Virtual On Demand and learn the best practices and emerging strategies needed to advance patient care in your everyday practice.

Three JACC Journals not previously included in Impact Factor rankings – JACC: Clinical Electrophysiology, JACC: Basic to Translational Science and JACC: CardioOncology – will receive their first Impact Factors later this year.

To grow the body of literature surrounding diabetes and heart failure, JACC: Heart Failure is accepting submissions for a focus issue on this topic planned for August of this year.

Join the ACC in recognizing World Cancer Day on Feb. 4 as part of American Heart Month. ACC’s Cardio-Oncology Section was created to improve the cardiovascular health of patients with cancer and cancer survivors through education, training, research development and interdisciplinary collaboration.

Immunotherapies have permanently changed the landscape of cancer therapy and there may be a continued expansion of the indications, complexity and targets leveraged to treat cancers, according to papers published Jan. 12 in JACC: CardioOncology.

In a new podcast episode following the recent issue of JACC: Cardio-Oncology, Andrea M. Russo, MD, FACC, discusses the patterns of anticoagulation use in cancer patients with atrial fibrillation and/or atrial flutter.

The new issue of JACC: CardioOncology, is now available online via open access.

Responding to the need for expanded knowledge on emerging trends, novel treatment approaches and outcomes for patients with AL and ATTR amyloidosis, JACC: CardioOncology will publish a special focus issue on this topic in 2021.

Register for ACC’s Advancing the Cardiovascular Care of the Oncology Patient Virtual meeting and join cardio-oncology leaders as they provide you with the best practices and emerging strategies needed to advance patient care in your everyday practice.

The newest issue of JACC: CardioOncology recently published, which is available entirely online for free via ppen access and features new summary podcasts recorded by Journal associate editors.

For many oncology patients, comorbid cardiovascular disease and newly developed cardiac conditions add complexity to their cancer treatment.

Attend the JACC: CardioOncology Virtual Journal Club on Tuesday, Oct. 27 from 10 – 10:30 a.m. ET for a live presentation and interactive discussion with experts on the recently published manuscript, Left Ventricular Systolic Function in Long-Term Survivors of Allogeneic Hematopoietic Stem Cell Transplantation.

Transendocardial injection of allogeneic mesenchymal stromal cells (allo-MSCs) may be safe and feasible in patients with anthracycline-induced cardiomyopathy (AIC), according to findings from the SENECA trial presented Sept. 30 during the Heart Failure Society of America Virtual Annual Scientific Meeting 2020 and simultaneously published in JACC: CardioOncology.

The latest issue of JACC: CardioOncology is now live, marking the Journal's one year anniversary. Editor-in-Chief Bonnie Ky, MD, MSCE, FACC, discussed Journal's success in the first year with JACC Editor-in-Chief Valentin Fuster, MD, PhD, MACC. Watch the video below.

Join the ACC and the Brazilian Society of Cardiology (SBC) for the first Cardio-Oncology International Virtual Symposium on Saturday, Sept. 12 at 7:30 a.m. – 5:30 p.m. ET/ 8:30 a.m. – 6:30 p.m. BRT.

Don't miss the June JACC: CardioOncology Patient Perspective Podcast. Editor-in-Chief Bonnie Ky, MD, MSCE, FACC, talks with husband and wife physicians, Jagmeet P. Singh, MD, PhD, FACC, and Noopur Raje, MD, about their personal experience with COVID-19.

The newly published issue of JACC: CardioOncology features an impressive lineup of content on heart failure and pregnancy in cancer survivors; imaging cardio-oncology; strain in AL Amyloidosis; CAR T therapy; cardiac monitoring in HER2+ therapy; resiliency in cardio-oncology; and more.

In the first installment of a new video series, JACC: CardioOncology Editor-in-Chief Bonnie Ky, MD, MSCE, FACC, is joined by Associate Editor Ron Witteles, MD, FACC; Wilson Gonsalves, MD; and Rola Khedraki, MD, for two insightful, informative 30-minute discussions on the topic of Amyloidosis.

Editor-in-Chief Bonnie Ky, MD, MSCE, FACC, will host the inaugural JACC: CardioOncology Virtual Journal Club on Tuesday, June 30 from 10 – 11 a.m. ET.

In a new Editor's Page published in the Journal of the American College of Cardiology (JACC), Editor-in-Chief Valentin Fuster, MD, PhD, MACC, and Justine Turco, ACC's divisional senior director of publishing, provide a look on how COVID-19 has impacted clinical care and peer-review publishing.

The third issue of JACC: CardioOncology has recently published, featuring new summary podcasts recorded by Journal associate editors.

Cardio-oncology is about innovation and is a field in its prime, boldly bringing two fields together to learn from each other and build something new.

Connect with cardio-oncology specialists from around the world at the Cardio-Oncology Section Meeting and Roundtable, taking place March 28 at 12:30 p.m. CT, at ACC.20 Together With World Congress of Cardiology.

Want to grow your cardio-oncology community? There's still time to register for ACC's Advancing Cardiovascular Care of the Oncology Patient course, taking place Feb. 14 – 16 in Washington, DC.

Join the ACC in recognizing World Cancer Day on Feb. 4 as part of American Heart Month. ACC's Cardio-Oncology Section was created to improve the cardiovascular health of patients with cancer and cancer survivors through education, training, research development and interdisciplinary collaboration.

The latest issue of JACC: CardioOncology features a lineup of original research, editorial comments, research letters, viewpoints, case challenges and more.

Chili Pepper Consumption and Mortality in Italian Adults by Marialaura Bonaccio, PhD, et al. received the most online attention among research published in the Journal of the American College of Cardiology (JACC) in 2019.

A recent series of ACC.org expert analyses features various perspectives on acute coronary syndrome (ACS) in older adults with recent or ongoing cancer treatment. The articles explain different cases and how they are handled through a geriatric, palliative care and cardio-oncology viewpoint.

ACC's newest JACC Journal, JACC: CardioOncology, has launched.

The highly anticipated second issue of JACC: CardioOncology features an impressive lineup of original research, reviews and case challenges on topics such as hypertension in cancer patients and survivors, ATTR amyloid, ischemia and bleeding in cancer patients undergoing PCI, cardiovascular prevention strategies in breast cancer, and more.

ACC's newest JACC Journal, JACC: CardioOncology, will publish its second issue on Tuesday, Dec. 17. The highly anticipated second issue will be feature state-of-the-art reviews, primers, research letters, viewpoints and case challenges on topics such as ischemia and bleeding in cancer patients undergoing PCI, hypertension in cancer patients and survivors, increased cancer prevalence in peripartum cardiomyopathy, and much more.

Many of us can remember that patient with heart failure – that woman with cardiomyopathy we discovered was due to anthracycline chemotherapy years earlier, around two decades ago. How can something meant to cure and help her end up hurting her? That is the predicament in which we find ourselves in cardio-oncology. We choose this field to be among those who bring hope, health and healing to many individuals who have ever been diagnosed with cancer.

The first issue of JACC: CardioOncology covered a range of topics and formats, check out its top five most downloaded articles!

There are a lot of big ways to get involved with the College – being on a Section Leadership Council, participating on a taskforce or committee, or serving as faculty for a live course, to name a few. However, we know that not everyone has the time for some of these larger-scale commitments. That's why the ACC is excited to announce the launch of our Microvolunteering Platform.

Applications are now being accepted for the ACC Leadership Academy Cohort IV, which will launch at ACC.20/World Congress of Cardiology in Chicago, IL.

Join world-renowned cardiologist and course director Valentin Fuster, MD, PhD, MACC, at ACC's New York Cardiovascular Symposium, taking place Dec. 6 – 8.

Join course directors Ana Barac, MD, PhD, FACC, and Bonnie Ky, MD, MSCE, FACC, at ACC's Advancing Cardiovascular Care of the Oncology Patient course, as they provide you with the best practices and emerging strategies needed to improve patient care in your everyday practice.

The first issue of ACC's newest JACC Journal, JACC: CardioOncology, is now online, providing a comprehensive new resource to better understand and apply evolving research surrounding the cardiovascular health of cancer patients and survivors.

The second issue of JACC: Case Reports is now online. Accompanied by a summary podcast from Editor-in-Chief Julia Grapsa, MD, PhD, FACC, the issue includes a mini-focus issue on interventional complications and their management, a heart care team/multidisciplinary team live case, clinical vignettes, an electrocardiogram challenge, a quality improvement project and many informative clinical cases.

Cardiology is the ACC's flagship member magazine — your member magazine — providing cardiovascular professionals with a comprehensive source for clinical and professional news. Find links to all of the July issue's articles and share on social media!

For researchers examining the complex and growing field of cardio-oncology, JACC: CardioOncology offers an excellent opportunity to publish in the highly read, highly ranked JACC Journals family.

The first issue of JACC: Case Reports – the newest JACC Journal – is now live.

The ACC has made a select number of travel awards available to cover expenses for members to travel to ACC's 2019 Legislative Conference, Nov. 3 – 5, in Washington, DC.

Preparing the cardiovascular workforce for the care of a growing population of cancer patients is necessary to enhance the delivery of high-quality cardiovascular care for these patients with cancer, according to a review paper published in the Journal of the American College of Cardiology.

The newest addition to the JACC family of journals, JACC: CardioOncology, is now accepting submissions.

Julia Grapsa, MD, PhD, FACC, and Bonnie Ky, MD, FACC, have been named Editors-in-Chief of the two newest JACC Journals – JACC: Case Reports and JACC: CardioOncology – launching in June and September, respectively.

Join the ACC in recognizing World Cancer Day on Feb. 4 as part of American Heart Month. ACC's Cardio-Oncology Section was created to improve the cardiovascular health of patients with cancer and cancer survivors through education, training, research development and interdisciplinary collaboration.

Join us at the ACC.19 All-Section Reception, March 17, from 6:30 p.m. – 8 p.m., at the Hilton New Orleans Riverside, Grand Ballroom A.

Individuals interested in applying for one of two new JACC Journal Editor-in-Chief positions must submit applications by Tuesday, Jan. 15.

Take advantage of free, online certified educational activities to fulfill your 2018 CME requirements and earn MOC credit at the same time!

Register today and save for ACC's Advancing the Care of the Oncology Patient live meeting, taking place Jan 25 – 27, 2019 in Washington, DC.

The deadline to submit abstracts for ACC's Advancing the Care of the Oncology Patient live meeting – taking place Jan 25 – 27, 2019 in Washington, DC – has been extended to Monday, Dec. 10.

In the latest issues of Cardiology, deep-dive into the emerging risk factors of gestational hypertension and preeclampsia.

The ACC is seeking applications for editor-in-chief of its new, online, open-access JACC: CardioOncology launching in 2019.

In this deep-dive video discussion, Valentin Fuster, MD, PhD, MACC; Deepak L. Bhatt, MD, MPH, FACC; Anne B. Curtis, MD, FACC; Peter Libby, MD, FACC; and Marc Ruel, MD, MPH, share their perspectives on the most significant science released during AHA.18.

The editors of the on ACC.org have created a new Cardio-Oncology Resources Page. The page is organized into 30 topics and nearly 100 subtopics in the field of cardio-oncology. The goal is to archive original clinical content curated by the editorial team as well as selected publications on relevant topics in an easy-to-navigate topic outline format. Users can drill down by topic to hand-picked articles and quizzes, and they can also submit suggestions for content or categories.

Join course directors, Ana Barac, MD, PhD, FACC and Bonnie Ky, MD, MSCE, FACC at Advancing the Cardiovascular Care of the Oncology Patient as they provide you with the best practices and emerging strategies needed to improve patient care in your everyday practice.

THRIVE, which aims to help improve quality of life for cancer survivors through innovative research and community building, is accepting letters of intent for up to six grants to academic or clinical researchers. As a partner in the inaugural Biden Cancer Summit, a total of $225,000 will be awarded. Letters of intent are due by Oct. 19.

The September 2018 issue of Cardiology, YOUR member magazine, is now live! Cardiology provides cardiovascular professionals with comprehensive clinical, professional and health policy news; feature-length articles on the top trends and innovations in cardiovascular medicine; expert commentary from leaders in the cardiovascular field; quick-read summaries of the latest research from the JACC Journals and other major cardiovascular journals; profiles of ACC members, like you; and so much more!

ACC.19 registration is NOW OPEN exclusively for ACC members. Nonmember registration will open Wednesday, Sept. 26. Register early for the lowest rates and best selection of hotel rooms!

Gastrointestinal (GI) and genitourinary (GU) bleeding are powerful predictors of new cancer diagnosis in patients with vascular disease, based on findings from the COMPASS Trial presented Aug. 26 at ESC Congress 2018.

While heart failure is an uncommon complication of breast cancer treatment, the risk may be higher in patients treated with certain types of chemotherapy and lower in younger patients, according to a study published Aug. 6 in JACC: Cardiovascular Imaging.

The August 2018 issue of Cardiology, YOUR member magazine, is now live! Cardiology provides cardiovascular professionals with comprehensive clinical, professional and health policy news; feature-length articles on the top trends and innovations in cardiovascular medicine; expert commentary from leaders in the cardiovascular field; quick-read summaries of the latest research from the JACC Journals and other major cardiovascular journals; profiles of ACC members, like you; and so much more!

The novelty of cardio-oncology and its associated concepts lends itself to administrative, clinical, research-related and educational challenges that may require attention in the near future as the field continues to advance, according to an article recently published in the Journal of the American College of Cardiology.

Enhance your knowledge in cardio-oncology by completing multiple patient cases for CME credit/MOC points in the Cardio-Oncology Case Series.

Several scientific societies have developed position papers, expert consensus articles and guidelines for clinical practice in the field of cardio-oncology, but most of them represent the position of only one specialty — either oncology/hematology or cardiology.

Test your knowledge with a Patient Case Quiz about a 45-year-old white man with history of chronic myeloid leukemia who was referred to the cardio-oncology clinic for cardiovascular assessment before beginning ponatinib.

A recent "Number Check" article published in Cardiology magazine provides statistics on patients with cancer and their risk of heart disease.

Several scientific societies have developed position papers, expert consensus articles and guidelines for clinical practice in the field of cardio-oncology, but most of them represent the position of only one specialty — either oncology/hematology or cardiology.

There has been a rapid growth in the field of cardio-oncology over the last several years, including an emerging focus on this topic by the ACC and other cardiology societies.

Health care in the U.S. has dominated the social, political and financial arena in the past decade, and the overall health of the population lags far behind other countries that spend much less. In this expert analysis, Anita Arnold, DO, FACC; Cathleen Biga, MSN, RN; and Debra Mariani, discuss why providers need to understand how their data are reported and coded and where they can look to see gaps in documentation.

On the rare occasion that primary cardiac tumors occur, about 75 percent are benign and 25 percent are malignant, and about 75 percent of the malignant tumors are sarcoma. Most cardiac surgeons and cardiologists will have minimal experience with primary cardiac malignancy.

A recent journal scan reviews a study that determined if heart failure (HF) is associated with cancer incidence and cancer-specific mortality. Using participants from the Physicians’ Health Studies I and II, which are two randomized controlled trials of aspirin and vitamin supplements that included annual health evaluations and determination of cancer and HF diagnoses, the authors confirmed that HF is not associated with an increased risk of cancer among male physicians.

The number of cancer survivors has increased in the last several decades due to rapid advances in therapy. Many of these patients are exposed to cardiotoxic regimens that can potentiate downstream cardiovascular risk, particularly on a background of shared medical and lifestyle risk factors for cardiac disease and cancer.

On Feb. 16 – 18, 2018, ACC’s Advancing Cardiovascular Care of the Oncology Patient meeting took place in Washington, DC. This educational opportunity was presented by emerging pioneers in cardio-oncology and offered interactive case discussions, debates, breakout sessions and roundtables, and evidence-based treatment strategies that address pre, intra and post-chemotherapy heart health.

Patients with a history of breast cancer or lymphoma may be more than three times as likely to develop heart failure (HF), according to research that will be presented at ACC.18 in Orlando.

A recent article published in Cardiology reviews how the ACC and many of its members have been actively involved in discussions related to cardio-oncology, particularly around new approaches to prevent or manage cardiovascular disease.

In the latest ACC Cardiology Hour, Valentin Fuster, MD, PhD, MACC, is joined by Deepak L. Bhatt, MD, MPH, FACC; Rachel J. Lampert, MD, FACC; Prediman K. Shah, MD, MACC; and Chadwick W. Stouffer, MD, in a roundtable discussion of the hottest trials from AHA 2017 in Anaheim, CA. Among the trials discussed are DACAB, CANVAS, EXSCEL, POISE-2 and more.

Thanks to the work of members of the Cardio-Oncology section and the Eastern Cooperative Group-American College of Radiology Imaging Network (ECOG-ACRIN) Cardiotoxicity Working Group, a new Cardio-Oncology resource for patients has been published on CardioSmart.org.

February 16, 2018 - February 18, 2018
The Ritz-Carlton, Washington, DC
Course Director(s): Ana Barac, MD,PHD,FACC; Bonnie Ky, MD, FACC

In the United States, an estimated 14.5 million individuals have a history of cancer, representing a prevalent and rapidly growing population that has benefited from remarkable advances in cancer treatment. Given this staggering statistic, clinicians often encounter patients with cancer and cancer survivors who have significant cardiovascular risk factors and cardiovascular disease. For the rapidly evolving cardio-oncology field, The American College of Cardiology presents Advancing Cardiovascular Care of the Oncology Patient, an educational opportunity education offering contemporary care strategies for healthcare providers involved in cardio-vascular care of cancer patients and cancer survivors. Join emerging pioneers in the field of cardio-oncology as they present, through interactive case discussions, debates, breakout sessions and roundtables, evidence-based treatment strategies that address pre, intra and post-chemotherapy heart health.

In conjunction with the ACC Committee Nominations cycle, the College’s Membership Committee is now accepting applications through Sept. 22. The Membership Committee was established as part of the 2015 College’s governance transformation and serves as standing committee of the College, reporting directly to the Board of Trustees.

The August 2017 issue of Cardiology, ACC’s flagship member magazine, is now live! Cardiology provides cardiovascular professionals with comprehensive clinical, professional and health policy news; feature-length articles on the top trends and innovations in cardiovascular medicine; expert commentary from leaders in the cardiovascular field; quick-read summaries of the latest research from the JACC Journals and other major cardiovascular journals; profiles of ACC members, like you; and so much more!

In line with the promise to meticulously define the role of cardiac imaging in managing various cardiovascular diseases around the world, JACC: Cardiovascular Imaging will publish a themed issue focusing on imaging in cardio-oncology in early 2018. The issue will highlight current and future roles of cardiovascular imaging in understanding the effects of cancer on the heart, as well as diagnosing, monitoring and treating these conditions.

The July 2017 issue of Cardiology, ACC’s flagship member magazine, is now live! Cardiology provides cardiovascular professionals with comprehensive clinical, professional and health policy news; feature-length articles on the top trends and innovations in cardiovascular medicine; expert commentary from leaders in the cardiovascular field; quick-read summaries of the latest research from the JACC Journals and other major cardiovascular journals; profiles of ACC members, like you; and so much more!

The ACC is seeking qualified candidates to serve as vice chair of the Annual Scientific Session for a two-year term of office for ACC.19 and ACC.20, moving on to assume another two-year term as chair of ACC.21 and ACC.22.

The June 2017 issue of Cardiology, ACC’s flagship member magazine, is now live! Cardiology provides cardiovascular professionals with comprehensive clinical, professional and health policy news; feature-length articles on the top trends and innovations in cardiovascular medicine; expert commentary from leaders in the cardiovascular field; quick-read summaries of the latest research from the JACC Journals and other major cardiovascular journals; profiles of ACC members, like you; and so much more!

ACC’s inaugural Advancing Cardiovascular Care of the Oncology Patient course was held February 17-18, 2017, in Washington, DC. Led by Course Directors Ana Barac, MD, PhD, FACC (Cardio-oncology Section Chair) and Bonnie Ky (Cardio-oncology Council member), this educational offering provided attendees with clinically relevant, state-of-the-art, best practice strategies in the assessment, diagnosis and management of cardiovascular concerns for patients with cancer and those requiring survivorship care.

Attending ACC.17? Join us for the All-Section Meeting & Reception at ACC.17! The event happening THIS Saturday, March 18, 2017 from 6:00 p.m. – 7:30 p.m. at the Marriott Marquis will give you a chance to learn more about what ACC's 19+ Member Sections are working to accomplish and to connect with members in your specialty or interest areas.

Save the Date for the All-Section Meeting & Reception at ACC.17! Happening on Saturday, March 18, 2017 from 6:00 p.m. – 7:30 p.m. at the Marriott Marquis, this event will give you a chance to learn more about what ACC’s 19+ Member Sections. Submit your RSVP to attend.

Join a panel of speakers on Monday, Dec. 12 at 8:00 p.m. ET to hear about preventive medicine along with lifestyle modification, including adopting and/or adhering to a heart healthy diet, regular exercise habits, avoidance of tobacco products, and achieving or maintaining a healthy weight.

Mark your calendars and save the date for ACC’s inaugural Advancing Cardiovascular Care of the Oncology Patient course. Join colleagues and meet the experts in Washington, DC, Feb. 17 – 18 to receive case-based education and hands-on learning on the cardiovascular...

The U.S. Food and Drug Administration (FDA) is hosting a public Cardio-Oncology workshop on Sept. 22 from 8:00 a.m. – 4:30 p.m. ET. Co-chaired by Laleh Amiri-Kordestani, MD, and Ana Barac, MD, FACC, chair of ACC’s Cardio-Oncology Member Section, this workshop will provide a forum for discussion of cardiovascular toxicity assessment within oncology clinical trials.

The Spring issue of Cardiology magazine features an exclusive interview with Ana Barac, MD, FACC, chair of ACC’s newly established and rapidly developing Cardio-Oncology Section. “I have always been fascinated by molecular mechanisms, and I pursued clinical training to see how these mechanisms translate into disease and to help answer questions surrounding disease processes,” Barac explains...

The Cardio-Oncology Clinical Topic Collection is now live on ACC.org. Get the latest insights into this evolving specialty, including thoughts on the future of cancer treatments, the efficacy of various therapies, cardiotoxicity and more. Managed by Editorial Team Lead Monika Jacqueline Leja, MD, FACC, the Collection aims to provide a robust compendium of expert analyses, journal articles, clinical trials, news stories and more.